Maravai LifeSciences Announces November 2024 Investor Conference Schedule

Company Participation in Investor Conferences - Maravai LifeSciences, Inc. is scheduled to participate in two investor conferences in November 2024 [1][2] - On November 19, 2024, Kevin Herde, CFO, and Drew Burch, President of Nucleic Acid Production, will engage in a fireside chat at the Stifel Healthcare Conference in New York [1] - On November 21, 2024, Trey Martin, CEO, and Kevin Herde, CFO, will participate in a fireside chat at the Jefferies Healthcare Conference in London [2] Webcast Availability - A live webcast of each presentation will be accessible on the Maravai LifeSciences Investor Relations website [3] - An archived version of the webcast will be available after the events [3] Company Overview - Maravai is a leading life sciences company that provides critical products for drug therapies, diagnostics, and novel vaccines [4] - The company specializes in nucleic acid synthesis and biologics safety testing, serving many top biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies [4]